Article: Schering-Plough Announces CLARINEX(R) RediTabs(R) Launched For Indoor and Outdoor Allergies and Chronic Idiopathic Urticaria; No access to water? Don't Like to swallow pills? Nonsedating relief of indoor and outdoor allergies available in an orally disintegrating formulation.

Schering-Plough Corporation announced today that it has begun shipping CLARINEX(R) 5 mg RediTabs(R) tablets, a convenient, orally disintegrating tablet formulation of the prescription nonsedating antihistamine desloratadine, to wholesalers and other trade accounts across the United States. CLARINEX 5 mg RediTabs is the first orally disintegrating prescription antihistamine approved for the treatment of allergy symptoms caused by both perennial indoor and seasonal outdoor allergens and chronic idiopathic urticaria (CIU), or hives of unknown cause, in adults and children 12 years of age and older. CLARINEX RediTabs will be available in pharmacies nationwide by the first ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!